TCL Archive SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma September 29, 2006
TCL Archive Intarferon Results Promising, ACS Says, And commits Another $3.4 Million February 22, 1980